Epstein Secrets

ll. I wanted to update you on what I've been up to for the last two years. I was also hoping to talk with you to see if I might use the foundation's Lexington office conference room from time to time for my work and what I could provide in exchange for that. I am ccling Rich because I'm not sure if you st

1_01089030 EFTA02275302 Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapie

l. I wanted to update you on what I've been up to for the last two years. I was also hoping to talk with you to see if I might use the foundation's Lexington office conference room from time to time for my work and what I could provide in exchange for that. I am cc'ing Rich because I'm not sure if you sti

ou still use this email? Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapie

l. I wanted to update you on what I've been up to for the last two years. I was also hoping to talk with you to sec if I might use the foundation's Lexington office conference room from time to time for my work and what I could provide in exchange for that. I am cc'ing Rich because I'm not sure if you sti

ou still use this email? Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapie

l. I wanted to update you on what I've been up to for the last two years. I was also hoping to talk with you to see if I might use the foundation's Lexington office conference room from time to time for my work and what I could provide in exchange for that. I am &ling Rich because I'm not sure if you sti

you still use this email? Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapie

l. I wanted to update you on what I've been up to for the last two years. I was also hoping to talk with you to see if I might use the foundation's Lexington office conference room from time to time for my work and what I could provide in exchange for that. I am cc'ing Rich because I'm not sure if you s

ou still use this email? Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age- driven or degenerative diseases. Most of the therapie

ll. I wanted to update you on what I've been up to for the last two years. I was also hoping to talk with you to see if I might use the foundation's Lexington office conference room from time to time for my work and what I could provide in exchange for that. I am cc'ing Rich because I'm not sure if you st

ou still use this email? Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapies

ll. I wanted to update you on what I've been up to for the last two years. I was also hoping to talk with you to see if I might use the foundation's Lexington office conference room from time to time for my work and what I could provide in exchange for that. I am cc'ing Rich because I'm not sure if you st

you still use this email? Since working for your foundation, I continued to publish as a joumalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapies